EU GMP Audit: A Complete Guide to Compliance and Audit Readiness
EU GMP Audit – Comprehensive Guide
An EU GMP Audit is a vital procedure that pharmaceutical producers undergo in order to check if they are compliant with EU Good Manufacturing Practice requirements. An EU GMP Audit aims at the evaluation of production processes, quality management systems, documentation, personnel, equipment and operational controls in order to prove the consistency of the medicinal products’ quality according to established standards. If a pharmaceutical company intends to export its goods to the European Union, then EU GMP compliance is crucial for it.
What Is an EU GMP Audit?
An EU GMP Audit is the assessment of pharmaceutical manufacturing and quality systems regarding the applicable EU GMP guidelines published in EudraLex Volume 4. There are different types of EU GMP Audits, which can be performed by regulatory authorities, customers or any third-party auditor in order to assess the compliance and efficacy of the pharmaceutical quality system.
What Areas Does an European Union GMP Audit Cover?
Generally, the following areas are evaluated in an European Union GMP audit of a pharmaceutical manufacturer: Quality Management System: evaluation of QA procedures, deviations, change control and CAPA; Documentation: SOPs, Batch Manufacturing Records (BMR), Batch Packaging Records (BPR) and quality. Manufacturing Operations: Review of manufacturing processes, equipment qualification, cleaning validation and process controls. Data Integrity: Assessment of adherence to ALCOA principles, electronic records, audit trail and control of computerized systems. Quality Control: Inspection of analytical procedures, laboratory practices, investigation of Out of Specification results and stability testing. Personnel Training: Evaluation of employees’ qualifications, GMP training and competency records.Preparation for European Union GMP Audit
Efficient audit preparation calls for a planned and systematic approach. Regular internal audit reviews, GMP gap analysis, revision of controlled documents and CAPA efficiency assessment are required from pharmaceutical organizations.
Moreover, pharmaceutical companies have to conduct regular reviews of their employee training, supplier qualification, equipment maintenance and data integrity controls. The conducting of mock GMP audits allows identifying potential compliance issues before the external inspection.
Typical Audit Observations
Typical audit observations consist of non-compliance with documentation requirements, insufficient deviation investigation, insufficient employee training, improper data integrity controls and inadequate corrective and preventive actions. Application of risk-based quality management ensures avoiding compliance issues recurrence.
The EU GMP Audit is not only a regulatory requirement but a continuous process for improvement, quality assurance and safety of patients. By ensuring effective quality management, proper documentation, and GMP adherence, pharmaceutical companies can enhance their audit preparedness and ensure compliance with European regulatory standards.
Masuu Global promotes a proactive approach towards the quality and compliance of the pharmaceuticals industry and helps organizations understand the significance of GMP practices.
